Long-term Follow-up Study of Male Adults With Hemophilia B Previously Treated With Etranacogene Dezaparvovec (CSL222)

NCT05962398 · clinicaltrials.gov ↗
ENROLLING_BY_INVITATION
Status
56
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

CSL Behring